Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Platelets
|
November 17, 2016
Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals
J M Trevillyan, E E Gardiner, R K Andrews, et al.
AIDS (London, England)
|
August 16, 2001
Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs
A L Dunne, F M Mitchell, S K Coberly, et al.
HIV Medicine
|
January 31, 2009
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations
J Audsley, N Arrifin, L K W Yuen, et al.
Journal of Clinical Microbiology
|
August 5, 2011
Novel sensitive real-time PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation
M Kramski, A J Gaeguta, G F Lichtfuss, et al.
Journal of Neurovirology
|
March 10, 2015
HIV eradication symposium: will the brain be left behind?
B J Brew, K Robertson, E J Wright, et al.
Human Vaccines
|
October 3, 2006
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects
S Emery, C Workman, R L Puls, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Platelets
|
November 17, 2016
Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals
J M Trevillyan, E E Gardiner, R K Andrews, et al.
AIDS (London, England)
|
August 16, 2001
Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs
A L Dunne, F M Mitchell, S K Coberly, et al.
HIV Medicine
|
January 31, 2009
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations
J Audsley, N Arrifin, L K W Yuen, et al.
Journal of Clinical Microbiology
|
August 5, 2011
Novel sensitive real-time PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation
M Kramski, A J Gaeguta, G F Lichtfuss, et al.
Journal of Neurovirology
|
March 10, 2015
HIV eradication symposium: will the brain be left behind?
B J Brew, K Robertson, E J Wright, et al.
Human Vaccines
|
October 3, 2006
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects
S Emery, C Workman, R L Puls, et al.
Page
of 8